Lessons learned across clinical research departments

© Gajus / Fotolia.com

Lessons learned

The end of the year – it’s a time to finalize, to summarize, to reflect, and to learn in order to plan next steps and new projects most reasonably and efficiently.

At GKM, we have taken this chance for reflecting and thinking about past and current projects we have been entrusted with. We realized that after now almost 35 years in the business of clinical research, we are fortunate to have gained an extensive experience on a number of indications. Also, we recognized that naturally we profit from the familiarity and knowledge on the various study indication types – and that we would like to share this benefit.

Therefore, we started a project at GKM involving all clinical research divisions: medical advising & clinical safety, biostatistics, project management and data management. The result of this operation is the beginning of a documentation series we would like to call “Lessons Learned” – a collection of insights and learnings from our work in clinical research over the past years on different indication groups.

Today we would like to start off “Lessons Learned” with inflammatory bowel diseases, a group of indications which we have accompanied for 25 years. Insights from 11 clinical and non-interventional studies are presented in this short brochure. We hope to provide you with some useful tips and information. In case of any questions, please don’t hesitate to contact us!

We wish you happy reading, thinking and planning!

lessons learned inflammatory bowel diseases

© sean824 / Fotolia.com